Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrence”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Early research (Phase 1)Study completedNCT01548807
What this trial is testing

Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

Who this might be right for
Prostate Cancer Patients With Detectable PSA Following Prostatectomy
Abramson Cancer Center at Penn Medicine 19
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Not applicableStudy completedNCT02920229
What this trial is testing

68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated

Who this might be right for
68Ga-PSMA HBED-PET/CTProstate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,230
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Large-scale testing (Phase 3)UnknownNCT03864939
What this trial is testing

Application of Dried Human Amnion Graft to Improve Postprostatectomy Incontinence and Potency

Who this might be right for
ContinencePotencyComplication+1 more
German Centre for Assessment and Evaluation of Innovative Techniques in Medicine 328
Not applicableUnknownNCT03718260
What this trial is testing

PSMA-PET Registry for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 3,070
Testing effectiveness (Phase 2)Study completedNCT00283803
What this trial is testing

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 32
Not applicableNo Longer AvailableNCT01777061
What this trial is testing

Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan

Who this might be right for
Prostate Cancer
Wendell Yap, MD
Not applicableUnknownNCT04846894
What this trial is testing

Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT

Who this might be right for
Prostate Cancer
Jin-Sook Ryu 43
Not applicableStudy completedNCT01366053
What this trial is testing

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists

Who this might be right for
Prostate Cancer
CMX Research 125
Testing effectiveness (Phase 2)Ended earlyNCT01685255
What this trial is testing

The IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Who this might be right for
Ovarian CancerGenitourinary (GU) Tumors
Incyte Corporation 83
Early research (Phase 1)Active Not RecruitingNCT00977457
What this trial is testing

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate Cancer
City of Hope Medical Center 1,045
Large-scale testing (Phase 3)Looking for participantsNCT04242017
What this trial is testing

Long-term Better Than Short-term ADT With Salvage RT

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 394
Testing effectiveness (Phase 2)WithdrawnNCT04483414
What this trial is testing

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Metastatic to Bone
Dana Mathews
Not applicableUnknownNCT00213707
What this trial is testing

Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.

Who this might be right for
HCV Infection
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03796767
What this trial is testing

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+3 more
University of Utah 20
Testing effectiveness (Phase 2)Study completedNCT05806853
What this trial is testing

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 60
Testing effectiveness (Phase 2)WithdrawnNCT00694291
What this trial is testing

Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center
Load More Results